The pancreas secretes four types of proteolytic digestive proenzymes, which after activation give rise to trypsin, chymotrypsin, elastase and carboxypeptidase. In humans, three trypsinogen isoforms, cationic trypsinogen (PRSS1), anionic trypsinogen (PRSS2) and mesotrypsinogen (PRSS3); four chymotrypsinogen isoforms, chymotrypsinogen B1 (CTRB1), chymotrypsinogen B2 (CTRB2), chymotrypsinogen C (CTRC), and chymotrypsinlike enzyme-1 precursor (CTRL1) and at least three proelastase isoforms, proelastase 2A (ELA2A), proelastase 3A (ELA3A) and proelastase 3B (ELA3B) are present in the pancreatic juice. Expression of the proelastase 1 (ELA1) gene is evolutionarily suppressed in humans by mutations in the promoter region. The product of the proelastase 2B (ELA2B) gene has not been identified in pancreatic tissue or juice yet and experiments with recombinantly expressed proelastase 2B (ELA2B) indicate that this isoform, if exists, may be catalytically inactive. There are three digestive procarboxypeptidase isoforms expressed in the human pancreas, procarboxypeptidase A1 (CPA1), procarboxypeptidase A2 (CPA2) and procarboxypeptidase B (CPB), also referred to as procarboxypeptidase B1 (CPB1).
Here we describe methods we use in our laboratory for the expression, purification, activation and activity measurement of human digestive proteases. Although not tested in a systematic manner, the methodology should be generally applicable to most mammalian pancreatic digestive proteases. 
Expression and Purification of Recombinant Proteases

1A. Materials
1B. Bacterial Expression and In Vitro Refolding of Recombinant Human Trypsinogens
For high-yield expression, human pancreatic trypsinogens can be produced in E. coli as inclusion bodies (Figure 1) .
After in vitro refolding, trypsinogen can be purified by ecotin affinity chromatography (1) (2) (3) (4) (5) . The same protocol applies to cationic trypsinogen (PRSS1), anionic trypsinogen (PRSS2) and mesotrypsinogen (PRSS3). Samples were analyzed by 15% reducing SDS-PAGE followed by Coomassie Blue staining. 6. Re-suspend the cell pellet from an 50 mL culture in 6 mL 0.1 M Tris-HCl (pH 8.0), 5 mM K-EDTA solution and aliquot the suspension by 1mL into six microcentrifuge tubes (1.7 mL size).
7. Sonicate the cell suspension for 20 sec three times using an ultrasonic cell disruptor.
8. Collect the inclusion bodies by centrifuging at 16,000 g for 10 min at 4 o C in a microcentrifuge and resuspend the inclusion body pellets in 0.1 M Tris-HCl (pH 8.0), 5 mM K-EDTA.
9. Pellet the inclusion bodies by centrifugation again and repeat the washing two more times. The pellets from the six tubes can be combined to produce a single pellet at the end of the washing procedure. Note that bacterial genomic DNA contamination can make the inclusion body pellet viscous and difficult to pipet. The DNA is removed by the repeated washes and DNAse treatment is usually not necessary. Next morning, trypsinogens can be purified by ecotin affinity chromatography. Note: To prepare the refolding solution, first add solid L-cystine (oxidized form) to 50 mL refolding buffer in a ~200 mL Erlenmeyer flask and dissolve it by vigorous stirring at room temperature on a magnetic stirrer for 30 min; then add solid Lcysteine (reduced form), which will dissolve quickly. Before adding L-cysteine, equilibrate the refolding solution with argon for a 5 min by blowing the gas into the flask through a pipette tip poked through an aluminum foil cover. Because of the poor solubility of Lcystine, undissolved crystals may remain in the refolding solution. This has no impact on the refolding procedure.
1C. Bacterial Expression and In Vitro Refolding of Recombinant Human Proelastase 2A
We have been unsuccessful so far in expressing human proelastase 2A (ELA2A) in mammalian cell culture. Proelastase 2A (ELA2A)can be expressed as inclusion bodies in E. coli and purified with ecotin-affinity chromatography after refolding, however, yields are lower than those obtained with trypsinogens (6) (7) (8) . The bacterial expression and inclusion body isolation protocols are identical to those described above for trypsinogens. The unfolding and refolding steps for proelastase 2A (ELA2A) are different. The description below is an updated protocol compared to our previously published method (6 
1D. Expression of Human Trypsinogens, Chymotrypsinogens, Proelastases and Procarboxypeptidases in HEK 293T Cells
Expression in of pancreatic digestive protease zymogens can be also achieved in transiently transfected mammalian cell lines (7, 8) . We routinely use HEK 293T cells. The zymogens are secreted to the conditioned medium, where they typically reach micromolar concentrations. Using this method we were unable to express human proelastase 2A (ELA2A) and we find that expression levels of human cationic trypsinogen (PRSS1) are relatively low (9) . On the other hand, human anionic trypsinogen (PRSS2), 
Purification of Pancreatic Serine Proteases
2A. Materials
Liquid chromatography system, e. 
2B. Purification of Pancreatic Serine Proteases With Ecotin Affinity Chromatography
We routinely purify trypsinogens, chymotrypsinogens and elastases on 2 mL ecotin affinity column using a liquid chromatography system (4).
Human chymotrypsinogen B1 (CTRB1) chymotrypsinogen B2 (CTRB2) and proelastase 3A (ELA3A) bind poorly to ecotin but they can be readily purified after activation to chymotrypsins B1 and B2 and elastase 3A. Procarboxypeptdiases or carboxypeptidases do not bind to ecotin. IMPORTANT: because trypsin can activate all other protease zymogens, and chymotrypsin C can process trypsinogen activation peptides to a shorter from, NEVER purify these proenzymes on the same ecotin column. In our laboratory we keep two ecotin columns, one for trypsinogens and one for chymotrypsinogens and proelastases. 
Preparation of the ecotin affinity column
Ecotin is a serine-protease inhibitor from the periplasm of E. coli that inhibits all pancreatic serine proteases, including human trypsins, chymotrypsins and elastases. Thus, immobilized ecotin can be utilized as a universal affinity matrix for the purification of pancreatic serine proteases (4). Ecotin also forms relatively tight complexes with the inactive, zymogen forms of pancreatic serine proteases, and can also be used for affinity purification of the proenzymes. Exceptions are chymotrypsinogens B1 (CTRB1) and B2 (CTRB2), which bind poorly to ecotin. In our laboratory, we build our own ecotin affinity chromatography columns, by recombinantly overexpressing ecotin in the periplasmic space of E. coli; isolating the periplasm by osmotic shock and purifying ecotin by trypsin affinity chromatography.
Purified ecotin is then immobilized on aldehyde activated resin by reductive amination and loaded into a chromatography column.
Expression of recombinant ecotin in E. coli BL21(DE3) 
Preparation of periplasmic fraction
1. For best results, periplasm should be isolated immediately after growth. Alternatively, cells may be kept on ice overnight in pellet form, but this typically results in some cell lysis which contaminates the periplasm.
2. Resuspend the cell pellet in 400 mL of 30% sucrose, 20 mM Tris-HCl (pH 8.0), 5 mM K-EDTA. Incubate the suspension on ice for 10 min.
3. Pellet the cells by centrifugation at 15,000 g for 15 min. Preparation of trypsin affinity column for ecotin purification 
Purification of ecotin by trypsin-affinity chromatography
1. Centrifuge the ~220-250 mL supernatant for 15 min at 30,000 g at 4 o C and load on the trypsin affinity column in five runs of 50 mL each. Collect the flow-through from all runs and pool. Re-apply the pooled flow-through to the column. 3. Dialyze the eluate against two changes of 3.5 L distilled water or 1 mM HCl overnight. Confirm ecotin concentration and yield again, as described above. Purity may be verified by subjecting samples of 1-5 µL to SDS-PAGE. There may be low levels of ecotin degradation products present which are presumably generated by tryptic cleavages during chromatography on the trypsin column.
Although not necessary, you may obtain a precise concentration of functional ecotin in the preparation by titrating against active-site titrated bovine trypsin. 
Preparation of immobilized ecotin and the ecotin column
About 30 mg ecotin should be used for column preparation. If needed, ecotin from two separate purifications should be combined.
1. Dissolve the lyophilized ecotin in 3 mL 50 mM Na-phosphate (pH 7.5) buffer or PBS (pH 7.4) to 10 mg/mL final concentration.
2. Resuspend the Actigel ALD resin (supplied in a plastic bottle in 20% ethanol solution) by turning the bottle upside-down a few times. Insert a 60 mL Buchner funnel into a side-arm flask through a rubber stopper and attach the side arm to the house vacuum through a hose. Pour approximately 10 mL resin into the funnel and wash several times with 50 mM Na-phosphate (pH 7.5) or with PBS (pH 7.4) under suction to remove the ethanol and to equilibrate with the coupling buffer. The coupling buffer must be free of amines, therefore, phosphate-based buffers are recommended. Do not use Tris buffer or other amine-containing buffers. 
2C. Purifaction of Human Procarboxypeptidases A1, A2 and B1 with MonoQ Ion-Exchange Chromatography
Procarboxypeptidases or their active forms do not bind to ecotin. Purification of these proenzymes from conditioned media can be achieved using conventional ion-exchange chromatography (8).
1. Dialyze conditioned media containing procarboxypeptidase against 20 mM Tris-HCl (pH 8.0) and load directly onto a MonoQ HR 5/5 column at 1 mL/min flow rate through one of the pumps of a Pharmacia FPLC system or using a loading pump of the AKTA system.
2. Develop the column with a 0-0.5 M NaCl gradient applied over 30 min at a flow rate of 1 mL/min.
3. Collect 1 mL fractions and analyze peak fraction by running 15 µL on a 15% SDS-PAGE gel and stain with Coomassie Blue.
4. Use only the purest one or two fractions for experiments. Estimate concentrations of the purified zymogen solutions from their ultraviolet absorbance at 280 nm, using extinction coefficients calculated with the webbased tool at http://ca.expasy.org/tools/protparam.html. This method usually yields preparations of high but incomplete purity (80-95%). An affinity tag based method (e.g. see purification of His-tagged zymogens on a nickel column) is recommended if the presence of the affinity tag is not a concern.
2D. Purification of His-Tagged Pancreatic Proenzymes with Ni-Affinity Chromatography
The use of C-terminal affinity tags can significantly facilitate purification of recombinantly expressed pancreatic proenzymes (7) . We routinely purify chymotrypsinogen C (CTRC), chymotrypsinogen B1 (CTRB1), chymotrypsinogen B2 (CTRB2) carrying an affinity tag composed of 10 histidine residues (10His tag). We also tested the method with success for Histagged proelastase 2A (ELA2A), proelastase 3A (ELA3A) and proelastase 3B (ELA3B) as well as procarboxypeptidase A1 (CPA1). The use of a 6His tag should be as good as longer tags. Note that purification of active pancreatic proteases using this method is less consistent, probably because of partial proteolytic removal of the affinity tags. 2. Load the conditioned medium onto the cartridge at 4 mL/min flow rate through one of the pumps of a Pharmacia FPLC system or using a loading pump on the AKTA system. 6. Pool peak fractions and dialyze overnight against two changes of 3.5 liters of 50 mM NaH 2 PO 4 (pH 8.0) buffer containing 300 mM NaCl.
7. Concentrate the dialyzed proenzyme solution using a Vivaspin concentrator, as needed.
Concentration Determination by Active Site Titration
For most experiments, concentration estimated from UV absorbance is acceptable, as long as consistently applied. If precise concentrations of functionally active proteases are required, active site titration with ecotin can be performed (7) . Dissolve crystalline bovine trypsin in 0.1 M TrisHCl (pH 8.0), 1 mM CaCl 2 at an approximately 50 µM concentration and active-site titrate using pnitrophenyl p'-guanidinobenzoate (PNPGB). Prepare a 10 mM PNPGB stock solution in dimethyl formamide (DMF). To 990 µL trypsin solution add 10 µL 10 mM PNPGB, mix quickly and thoroughly, and measure OD immediately at 410 nm. Molarity of active trypsin present is calculated from the formula OD×6.025×10 -5 . Next, determine the concentration of a purified ecotin solution by titration against the active-site titrated bovine trypsin. This titrated ecotin batch will serve then as a universal titrant for all human pancreatic serine proteases. Perform titrations using protease concentrations at least two orders of magnitude above the equilibrium dissociation constants (K D ) of ecotin with human pancreatic proteases. This may be impractical with the relatively weakly binding elastase 3A (ELA3A) which can be titrated at a concentration ~5-10-times above K D .
Measurement of Protease Activity with Peptide Substrates
The activity of proteases can be determined using chromogenic or fluorogenic peptide substrates. These substrates are equally useful for assaying purified proteases or protease activity in conditioned medium, pancreatic juice or pancreatic tissue homogenate.
We prefer chromogenic substrates with a p-nitroaniline (pNA) leaving group, because the initial substrate concentrations can be more easily defined and the substrate consumption can be readily converted to concentrations using the extinction coefficient of pNA, which is 10,400 M -1 ·cm -1 at 405
nm. Please note that in microplate readers the extinction coefficient needs to be corrected for the shorter light path. We routinely use N-CBZ-GlyPro-Arg-pNA for trypsin, N-Suc-Ala-Ala-Pro-PhepNA for chymotrypsin, N-Suc-Ala-Ala-Pro-AlapNA for ELA3A and ELA3B and N-Suc-Ala-AlaPro-Leu-pNA for ELA2A. Release of the yellow pNA is followed for 1-2 min at 405 nm in 0.1 M 
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